Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $797,914 (100.0% shares, 0.0% debt)

Holdings (12)

— MEDICINES CO. 26.3%

Value ($000) $210,100 Shares 4,202,000 Est. Cost $27.97 Unrealized —

— ALLERGAN PLC 22.0%

Value ($000) $175,442 Shares 1,042,500 Est. Cost $153.51 Unrealized —

BIIB BIOGEN INC. 18.8%

Value ($000) $149,703 Shares 643,000 Est. Cost $278.12 Unrealized -16.3%

IRWD IRONWOOD PHARMACEUTICALS INC. 10.9%

Value ($000) $86,734 Shares 10,103,000 Est. Cost $11.74 Unrealized -17.2%

INVA INNOVIVA INC. 8.2%

Value ($000) $65,790 Shares 6,242,000 Est. Cost $12.99 Unrealized -8.0%

— INTERCEPT PHARMACEUTICALS INC. 7.1%

Value ($000) $56,472 Shares 851,000 Est. Cost $87.00 Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 3.9%

Value ($000) $31,009 Shares 242,000 Est. Cost $132.69 Unrealized +1.0%

PBYI PUMA BIOTECHNOLOGY INC. 1.9%

Value ($000) $15,254 Shares 1,417,000 Est. Cost $30.04 Unrealized -64.1%

— MERSANA THERAPEUTICS INC. 0.7%

Value ($000) $5,925 Shares 3,750,000 Est. Cost $5.26 Unrealized —

— REGULUS THERAPEUTICS INC 0.2%

Value ($000) $1,333 Shares 1,851,851 Est. Cost $1.25 Unrealized —

— MIRATI THERAPEUTICS INC. 0.0%

Value ($000) $77 Shares 1,000 Est. Cost $42.00 Unrealized —

ABBV ABBVIE INC. 0.0%

Value ($000) $75 Shares 1,000 Est. Cost $38.85 Unrealized +35.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDICINES CO.	4,202,000	$210,100	26.3%	$27.97	—	COM	584688105
—	ALLERGAN PLC	1,042,500	$175,442	22.0%	$153.51	—	SHS	G0177J108
BIIB	BIOGEN INC.	643,000	$149,703	18.8%	$278.12	-16.3%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC.	10,103,000	$86,734	10.9%	$11.74	-17.2%	COM CL A	46333X108
INVA	INNOVIVA INC.	6,242,000	$65,790	8.2%	$12.99	-8.0%	COM	45781M101
—	INTERCEPT PHARMACEUTICALS INC.	851,000	$56,472	7.1%	$87.00	—	COM	45845P108
JAZZ	JAZZ PHARMACEUTICALS PLC	242,000	$31,009	3.9%	$132.69	+1.0%	SHS USD	G50871105
PBYI	PUMA BIOTECHNOLOGY INC.	1,417,000	$15,254	1.9%	$30.04	-64.1%	COM	74587V107
—	MERSANA THERAPEUTICS INC.	3,750,000	$5,925	0.7%	$5.26	—	COM	59045L106
—	REGULUS THERAPEUTICS INC	1,851,851	$1,333	0.2%	$1.25	—	COM NEW	75915K200
—	MIRATI THERAPEUTICS INC.	1,000	$77	0.0%	$42.00	—	COM	60468T105
ABBV	ABBVIE INC.	1,000	$75	0.0%	$38.85	+35.4%	COM	00287Y109